| Immunopeptidomics-based design of mRNA vaccine formulations against Listeria monocytogenes RL Mayer, R Verbeke, C Asselman, I Aernout, A Gul, D Eggermont, ... Nature Communications 13 (1), 6075, 2022 | 47 | 2022 |
| Transport by circulating myeloid cells drives liposomal accumulation in inflamed synovium J Deprez, R Verbeke, S Meulewaeter, I Aernout, H Dewitte, T Decruy, ... Nature Nanotechnology 18 (11), 1341-1350, 2023 | 20 | 2023 |
| Alpha-galactosylceramide improves the potency of mRNA LNP vaccines against cancer and intracellular bacteria S Meulewaeter, I Aernout, J Deprez, Y Engelen, M De Velder, ... Journal of Controlled Release 370, 379-391, 2024 | 6 | 2024 |
| Photoporation of NK-92MI cells with biodegradable polydopamine nanosensitizers as a promising strategy for the generation of engineered NK cell therapies C Hinnekens, A Harizaj, D Berdecka, I Aernout, M Shariati, S Peeters, ... Applied Materials Today 40, 102402, 2024 | 2 | 2024 |
| Immunopeptidomics mapping of Listeria monocytogenes T cell epitopes in mice A Gul, LL Pewe, P Willems, R Mayer, F Thery, C Asselman, I Aernout, ... Molecular & Cellular Proteomics 23 (9), 100829, 2024 | 1 | 2024 |
| Current State of mRNA Vaccine Development Against Mycobacterium tuberculosis I Aernout, R Verbeke, SC De Smedt, F Impens, I Lentacker Trends in mRNA Vaccine Research, 325-335, 2025 | | 2025 |
| The role of mRNA-galsomes and LNPs in enhancing HIV-specific T cell responses across various lymphoid organs S D’haese, S den Roover, R Verbeke, I Aernout, S Meulewater, J Cosyns, ... Molecular Therapy Nucleic Acids 35 (4), 2024 | | 2024 |
| Immunopeptidomics-based design of mRNA vaccine formulations against Listeria I Aernout, A Gul, D Eggermont, K Boucher, F Thery, TM Maia, H Demol, ... Nature Communications 13, 6075, 2022 | | 2022 |
| Immunopeptidomics-based design of highly effective mRNA vaccine formulations against Listeria monocytogenes RL Mayer, R Verbeke, C Asselman, I Aernout, A Gul, D Eggermont, ... | | |
